Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels

The loss of tumour phospho-extracellular responsive kinase (pERK) positivity is the major treatment biomarker for mitogen-activated protein kinase/extracellular responsive kinase (MEK) inhibitors. Here, we demonstrate that there is a poor correlation between pERK inhibition and the anti-proliferativ...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Smalley, K S M, Contractor, R, Haass, N K, Lee, J T, Nathanson, K L, Medina, C A, Flaherty, K T, Herlyn, M
格式: Artigo
語言:Inglês
出版: Nature Publishing Group 2007
主題:
Translational Therapeutics
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360037/
https://ncbi.nlm.nih.gov/pubmed/17245336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603596
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍